Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03452111 · ClinicalTrials.gov registry record · Phase 2
Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception
A Phase 2 study, sponsored by Premier Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 420
- Enrollment target
NCT03452111 is a Phase 2 study that has completed, run by Premier Research. The registered enrollment target is 420 participants.
The verdict
NCT03452111, a Phase 2 study, has completed, sponsored by Premier Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 420 participants
- Enrollment target
Study Summary
The long term objective is to develop a gel to be used as a male contraceptive.
Interventions
- DRUG Nestorone + Testosterone Combination Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2018-10-25 |
| Est. Completion | 2024-09-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03452111
The ClinicalTrials.gov registry entry for NCT03452111 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Premier Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nestorone + Testosterone Combination Gel is the first listed.
NCT03452111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03452111 about?
NCT03452111 is a clinical study titled "Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception". The long term objective is to develop a gel to be used as a male contraceptive.
What is the current status of trial NCT03452111?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 420 participants. The study started on 2018-10-25. Estimated completion is 2024-09-06.
What interventions are being tested in trial NCT03452111?
The interventions under investigation include: Nestorone + Testosterone Combination Gel (DRUG).
Who is sponsoring clinical trial NCT03452111?
This trial is sponsored by Premier Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.